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Abstract: In the treatment of patients with dementia types such as 
Alzheimer’s, non-current and tough situations are faced. Treatment should 
be tailored to each stage of the disease and for each patient. In this type of 
disease, it is very important to involve families and caregivers to improve the 
patients´ quality of life. The main goal with these patients is prevention. All 
oral manifestations caused by the lack of inadequate oral hygiene, xerostomia 
and manifestations derived from taking drugs should be controlled. The aim 
of this review is to describe the main oral manifestations which can result 
from this disease and the best treatment options taking into account the pa-
tients’ clinical stages.
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INTRODUCTION.
Dementias are multifactorial diseases. They are charac-
terized by an acquired and persistent deterioration of the 
intellectual function, with involvement of at least three 
areas of mental activity such as memory, language, visual-
spatial, emotional skills, personality disorders and deficits 
in cognitive ability, being severe enough to interfere with 
the patient’s daily life activities1-6. 
Age is the major risk factor in cases of dementia, being 
more commonly found in individuals aged 85 and over. 
Although, according to the literature, there are significant 
variations in prevalence, ranging from 3% for those 65 to 
74-year-olds and 47% for those older than 853. This preva-
lence implies the possibility of a dentist finding a person 
with dementia is considerable1-6. 
Among all dementia types, Alzheimer’s disease com-
prises over 50% of cases, with a higher incidence in Afro-
American and Hispanic people compared with the white 
population and a higher prevalence in women. In order of 
frequency, it is followed by vascular dementia with 16%, 
and the remaining 30% belonging to other dementias, such 
as frontotemporal, the Lewy body disease, mixed dementia 
and Creutzfeldt-Jakob3. 
Dementia patients go through different clinical stages 
with progressive deterioration ranging from the absence of 
cognitive impairment to severe cognitive impairment3,4,6. 
Alzheimer’s disease is a progressive degenerative process 
in cognitive function of unknown origin. It involves a gra-
dual and continuous deterioration of memory, orientation, 
emotional stability, abstract thinking, motor skills and per-
sonal care4-7. 
The main clinical symptoms of the disease are 4: aphasia 
(loss of the ability to use speech and language), apraxia (loss 
of ability to perform learned and familiar movements), visual 
agnosia (inability to recognize familiar visual stimuli) and 
memory disorders4-7. 
The course of the disease can vary from patient to pa-
tient, but it generally develops in 3 stages. In the first one, 
the most characteristic sign is the loss of memory and tem-
poral disorientation, loss of spontaneity, and even dete-
rioration in physical presence and hygiene. In the second 
phase, patients suffer a rapid loss of intellectual capacity, 
observation skills, sense of humor, self-recognition, lan-
guage comprehensibility and motor skills deteriorate along 
with a partial or total loss of speech. In the last phase, also 
called terminal phase, the patient is apathetic, disoriented 
and without the ability to communicate and even sudden 
changes in mood, depression and behavioral problems as 
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well as verbal or physical aggression appear. Also, seizu-
res or incontinence can occur in advanced stages4-7. Other 
authors such as Friedlander et al. proposed seven different 
stages of the natural process of self cognitive impairment of 
the disease3. 
It is essential to make a correct diagnosis of these disea-
ses through a good medical history which includes a com-
plete physical, psychiatric and neurological evaluation in 
order to identify cognitive deficits and to rule out other 
pathologies with similar clinical manifestations, such as 
hypothyroidism, Cushing’s syndrome, depression, vitamin 
B12 deficits, electrolyte imbalances, Parkinson’s disease, 
neurosyphilis or HIV infection4-7. 
The main oral manifestations of Alzheimer’s disease are 
usually due to lack of proper maintenance of oral hygiene, 
improper control of bacterial plaque, xerostomia and those 
derived directly from drugs1,2,5-7. 
Oral care, treatment planning and behavior manage-
ment in individuals with dementia should be designed 
taking into consideration the severity of the disease and 
should involve family members and caregivers1-6. 
The aim of this review is to describe the main oral 
manifestations which can result from this disease and the 
best treatment options taking into account the patients’ 
clinical stages.
ORAL MANIFESTATIONS OF ALZHEIMER’S 
DISEASE.
In patients with Alzheimer’s disease, there are several 
oral findings due to improper maintenance of oral hygie-
ne as a result of the failure to remember its importance, 
an incorrect control of bacterial plaque, the presence of 
xerostomia and manifestations derived directly from me-
dicines (gingival overgrowths in patients treated with an-
ticonvulsant drugs)1-4,6,7. 
The deficiency in the oral hygiene patients with this 
disease can trigger a number of dental problems which 
include: caries, periodontal disease, gingivitis, halitosis 
and a progressive destruction of teeth which can eventua-
lly cause systemic consequences such as difficulty to feed 
themselves adequately1-4,6,8. 
The decrease in salivary flow leads to alterations in the 
flora of the oral cavity, mucous membranes look smooth 
and pale and the tongue has a red and dry appearance with 
a tendency to crack. Patients may complain of burning 
mouth sensation, changes in speech, taste, swallowing di-
sorders and halitosis. There is also the occurrence of ulcers 
by friction due to reduced adhesion of the prosthesis sup-
ported by the oral mucosa. Besides, reduced salivary flow 
leads to a reduction in salivary components allowing the 
occurrence of oral infections like candidiasis1-6,9-11. 
Candidiasis.
Microorganisms of the Candida genus are present in the 
oral cavity of about 50% of the population without causing 
disease, yet, when acting as infectious agents, they may cause 
candidiasis12. 
Bacteria accumulating in the removable prosthesis are an 
important factor in the pathogenesis of stomatitis caused by 
prosthesis13. In the prostheses, there is a biofilm formed by 
fungi, bacteria and sloughed epithelial cells which acts as a 
reservoir for the oral microorganisms13. 
Chronic atrophic candidiasis is an inflammation of the 
mucosa which is located underneath the acrylic prosthe-
sis12, Candida albicans being the main etiological agent of 
this infection12,14. 
Proper routine cleaning of the prosthesis is necessary 
for preventing stomatitis caused by these microorganisms 
and to keep healthy supporting tissue12,14. 
In elderly or patients with mobility problems, chemi-
cals to clean the prosthesis may be helpful. Commercial 
products available today can be divided into five groups: 
alkali peroxides, alkaline hypochlorite, dilute organic 
and inorganic acids, disinfectants and enzymes. Immer-
sion cleaning is the most common technique due to its 
convenience. Besides cleaning, this procedure deconta-
minates the prosthesis through the destruction of mi-
croorganisms by cleaning chemicals13. 
There are studies comparing the occurrence of Can-
dida yeast on denture with metal alloy and resin, being 
most prevalent in resin. The aging of the acrylic resin 
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leads to deterioration characterized by increased porosi-
ty, making the surface more and more rough, promoting 
colonization of microorganisms12. 
According to Gusmão et al.12, people who do not re-
move their prosthesis at night have a higher prevalence of 
Candida yeast. 
Prevalence of stomatitis related to the use of dentures 
varies between 25 and 66.7% and it is more often in older 
people or those who have reduced motor skills living in 
nursing homes14.
Candida treatment consists of directly applying an an-
tifungal to the affected area or to the right surface of the 
prosthesis. This treatment may be compromised by the 
difficulty for application in disabled patients. Therefore, 
we should always administer the treatment that is easier 
to implement and requires less frequent applications. The 
most often used drug to inhibit the growth of Candida is 
Nystatin, it is the most used antifungal in dentistry, with 
topical or systemic application14.
Xerostomia.
Saliva serves to lubricate and protect the oral cavity; it 
helps to form the food bolus and facilitates swallowing 
and speech. Regarding teeth, it has a mechanical clea-
ning action, reduces the amount of oral microorganisms, 
neutralizes acids of the bacterial metabolism of the bio-
film (buffering capacity) and provides inorganic ions of 
calcium phosphate to the hard dental tissue during re-
mineralization15. 
It was long believed that the decrease in salivary f low 
was produced by age and disability of the salivary glands 
to produce saliva. Today, literature supports the fact that 
some drugs also contribute significantly to the reduc-
tion of saliva production. This reduction or absence of 
salivary f low may occur by the interference caused by 
the autonomic nervous system or by direct action on the 
acinar cells8. 
Medication plays an important role in reducing the 
unstimulated salivary flow, while a dry mouth is associa-
ted with other factors such as anxiety and stress. Anti-
hypertensives and antidepressants belong to the group of 
drugs which are likely to adversely interfere with the pro-
duction of saliva8. 
The effects produced by the drugs often occur more ea-
sily in the elderly. It is believed that this occurs by a strong 
expression of the drug as a result of decreased serum albu-
min and the half-life of drugs in the blood of older people 
is higher due to its elimination. Its elimination may be 
affected by renal dysfunction and a slow metabolism10. 
Patients with Alzheimer’s disease have xerostomia 
due to anticholinergic and anxiolytic drugs10. In cases of 
Parkinson’s dementia, antiparkinsonian drugs are also ca-
tegorized as one of the most xerostomizing10.
DENTAL TR EATMENT AND PR EV EN-
TION MEASUR ES 
The goal of treatment in the oral cavity will be pre-
vention according to each stage of illness the patient’s 
physical and emotional capacity. The patient’s oral health 
should be improved for a better quality of life and thus 
avoid an increased risk of heart disease (bacteremia) or 
bacterial pneumonia aspiration4-7. 
When diagnosing a condition of such nature, a review and 
complete rehabilitation of the oral cavity should be conduc-
ted, since failure to maintain good oral health can lead to 
malnutrition increasing the risk of oral infections4-7. 
Preventive measures aimed at controlling bacterial 
plaque, xerostomia and use of removable dentures should 
be taken4-7. 
Firstly, the patient’s motor skills to maintain proper 
control of bacterial plaque must be considered. Because 
of the patient’s motor difficulties to keep bacterial plaque 
under control, the assistance of professional hygiene in 
the dental clinic and caregivers or family in the patient’s 
home will be required1-4,6,7. 
Regarding the mechanical treatment of the plate, stu-
dies recommend the use of electric toothbrushes with 
f luoridated toothpaste16. 
Using a chemical control adjunct to mechanical plaque 
is fundamental. Mouthwash should be used as long as 
the patient retains the ability to rinse. The most widely 
Alzheimer’s disease: oral manifestations, treatment and preventive measures.
Ortega-Martínez J, Cedeño-Salazar R, Requena C, Tost M & Lluch A. 
J Oral Res 2014; 3(3): 184-189
187ISSN Online 0719-2479 - ©2014 - Official publication of  the Facultad de Odontología, Universidad de Concepción - www.joralres.com
used antiseptic chlorhexidine is 0.12 at 0.2%. In cases 
where the patient retains the ability to rinse, there are 
other presentations of chlorhexidine such as spray, gel or 
varnish with a maximum time of 15 days to avoid dental 
staining4-7. This antimicrobial tenfold reduced plaque. 
The presence of alcohol is contraindicated in cases such 
as mucositis, radiation sensitive tissues of the head and 
neck, and immunocompromised patients and those with 
composite resin restorations13,17. 
Poor oral hygiene can lead to the loss of most teeth. 
This fact would cause the need for a removable prosthe-
sis. However, adaptation and use in patients with demen-
tia is very limited because of their cognitive impairment 
and motor deficits4-7. 
Secondly, the consequences of xerostomia should be pre-
vented by using local salivary stimulants (gum with xylitol, 
parasympathomimetic drugs or salivary substitutes)4-7. 
In advanced stages, the dental treatment becomes in-
creasingly difficult, sometimes requiring the use of gene-
ral anesthesia to avoid general medical risks4-7.
DISCUSSION. 
Currently, aging leads to an increase in the incidence 
of dementiain our society. This increases the likelihood 
of having to treat people who suffer it. Literature agrees 
that Alzheimer’s disease is the most common type of  de-
mentia in the elderly, followed by vascular dementias1-7. 
Referring to the prevalence of these diseases, an increa-
sed susceptibility to suffer them is seen in old age, this 
being the main risk factor6. Additionally, Friedlander et 
al.3 concluded that there is a higher incidence in Afro-
American and Hispanic people and a higher prevalence 
in women. There are even studies linking the possible 
onset of dementia with the patient’s dental hygiene prior 
to AD18. In this study, a reduced risk of dementia was 
observed in subjects with lower educational level due to 
the absence of infectious foci18 .
According to literature, early diagnosis is essential to 
favorably modify the disease although healing is virtually 
impossible. It also helps in ruling out other diseases1-4,6,7. 
In Alzheimer s´ disease, apart from impaired cognitive 
function, patients’ daily activities are affected. In lite-
rature, there is a coincidence in the presence of clinical 
signs, such as apraxia and apathy, as responsible for cau-
sing such people to have a disinterest, neglect themselves 
and experience inability to run a proper oral hygiene te-
chnique at intermediate stages of the disease 4,7. 
Poor oral hygiene and oral health lead to the appea-
rance of a series of oral manifestations, such as coronal 
and root cavities4, periodontal disease, gingivitis, hali-
tosis, prosthesis induced ulcers and even the presence 
of fungal infections (candidiasis)1,3,5,6. That is why pre-
ventive measures must be taken and family members 
must be educated to avoid possible complications due 
to poor oral hygiene3-4. 
Silvestre et al.7 specifies a classification of oral mani-
festations that can be caused by AD. They are classified 
in manifestations derived from oral hygiene, xerostomia, 
drugs and various other causes. 
For greater plaque removal, several scientific articles, 
such as Verma et al.16 and Visschere et al.19, recommend 
the use of electric toothbrushes for these patients. Ne-
vertheless, I seri et al.13 and Silvestre et al.7 recommend a 
plaque chemical adjuvant to mechanical treatment. The-
se articles recommend chlorhexidine 0.12%, modifying 
its presentation depending on the patient5,13,16,19. 
AD patients are treated with drugs which improve 
cognitive performance, such as acetylcholinesterase in-
hibitors, and others to relieve the rest of symptoms such 
as NSAIDs, anticonvulsants, anxiolytics and antioxi-
dants1-4,7. Literature agrees on the presence of xerostomia 
and gingival hyperplasia as the main manifestations deri-
ved from drug treatment7,8,10,15,20. 
Candidiasis and xerostomia are not exclusively caused 
by AD, but they appear more frequently due to a set of 
characteristics favoring such clinical situations in patients 
with AD, like advanced age, intake of drugs which can de-
crease salivary flow and lack of self-hygiene due to cognitive 
degradation8.12. 
Regarding removable dentures, there are several factors 
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which increase the risk of stomatitis or chronic atrophic 
candidiasis13. One of them is the presence of the prosthesis 
during sleep12 and the material it is made of, resin being re-
lated to the growth of Candida12, the mobility of removable 
prosthesis7 and improper cleaning of dental prostheses13.
CONCLUSION.
Currently, there is an increase in life expectancy, increa-
sing the possibility of treating people with Alzheimer’s disea-
se or other dementia in Dentistry. 
This requires adequate training of professionals to provide 
a quality service. Early diagnosis is crucial to prevent all the 
complications of the disease and begin treatment to reduce 
its progression. 
Further randomized controlled studies with an accepta-
ble follow-up period to reinforce the use of the treatments 
described in this review and future innovative treatments to 
help improve the quality of life of our patients are needed.
Enfermedad de Alzheimer: manifestaciones ora-
les, tratamiento y medidas preventivas.
Resumen: En el tratamiento a pacientes con demen-
cias tipo Alzheimer se afrontan situaciones infrecuentes y 
comprometidas. El tratamiento debe personalizarse para 
cada estadio de la enfermedad y para cada paciente. En este 
tipo de enfermedades es muy importante involucrar a los 
familiares y cuidadores para mejorar la calidad de vida del 
enfermo. El principal objetivo con estos pacientes es la pre-
vención. Se deben controlar todas las manifestaciones orales 
provocadas por la falta de una inadecuada higiene oral, la 
xerostomía y las manifestaciones derivadas por los fármacos 
que consumen. 
El objetivo de esta revisión es describir cuáles son las 
principales manifestaciones orales que pueden derivar de 
esta enfermedad y las mejores opciones de tratamiento 
teniendo en cuenta las etapas clínicas en las que se en-
cuentran los pacientes.
Palabras clave: Alzehimer, Demencia, Salud oral, 
Enfermedad, Prevención
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